Breucking E, Mortier W, Lampert R, Brandt L
Institut für Anästhesie, Stadt Wuppertal.
Anaesthesist. 1993 Oct;42(10):719-23.
Since 1983 we have been involved in the diagnostic work-up and emergency treatment of a female patient now 48 years old who has a mitochondrial myopathy resembling Luft's disease. The syndrome was first described in 1959, and in more detail in 1962, by Luft and et al., who reported a picture of hypermetabolism with high temperature, extreme sweating, tachycardia, dyspnoea at rest, polydipsia, polyphagia and irritability but normal thyroid function. In 1971 and 1976 Haydar and Di Mauro presented a second case and proposed treatment with chloramphenicol. Our patient has the third case of the syndrome reported so far: her case was initially published in 1987. CASE REPORT. Since her 17th year of life the patient had suffered from episodes of fever, tachycardia and sweating. At the age of 32 these attacks worsened, leading to unconsciousness and apnoea. The patient then had to be intubated, ventilated and sometimes resuscitated. The diagnosis of MH susceptibility and Luft's disease was made on biochemical grounds after the first muscle biopsy in 1983. Therapy with chloramphenicol failed. Therapy with beta blockers, vitamin C and K or E, coenzyme Q10 and a high-caloric diet was started in 1985. The patient was registered with an emergency service, which flew her to our ICU whenever she had a severe crisis. For milder episodes she was supplied with an oxygen breathing mask at home. Myalgia increased with the episodes starting in 1988, and the patient needed dantrolene infusions and analgesics at home. To facilitate venepuncture a Port-A-Cath system was implanted in 1987, which had to be removed four times due to infection and sepsis. A muscle biopsy was taken in Rotterdam, which revealed differences in mitochondrial function from the biochemical findings recorded in 1983 and not in keeping with Luft's disease. Unfortunately, the patient was not able to undergo further metabolic investigations or therapeutic trials. ANAESTHESIA. The patient received three local and six general anaesthetics in our clinic. The muscle biopsies, two in 1983 and one in 1985, were performed under local infiltration with procaine and were uneventful. The general anaesthetics were carried out without MH trigger substances following pretreatment with dantrolene for the following surgical procedures: the repair of an extensive arterio-venous fistula between the brachiocephalicus trunk and the right jugular and subclavian vein, revision of the sternum cerclage, implantations and explanations of infectious Port-A-Cath systems. We used etomidate, propofol and fentanyl or alfentanil with nitrous oxide and oxygen for induction and maintenance of anaesthesia. Muscle relaxation was induced with vecuronium or atracurium. All cardiovascular, respiratory, metabolic and temperature measurements stayed in normal ranges. After the extensive vascular repair (av fistula) the patient had to be mechanically ventilated for some hours until normal body temperature was restored. At the end of all other periods of anaesthesia she was extubated in the operating theatre. In five cases the postoperative period was uneventful. Only once she developed a crisis with hyperthermia, tachycardia, sweating and dyspnoea. INTENSIVE CARE. From 1985 to 1992 the patient was treated in our ICU 21 times. On 11 occasions she was already intubated and being ventilated by the emergency service on arrival. Extubation was usually possible within 2-20 h. During the crisis, heart rate was about 160-190 per minute and temperature above 40 degrees C. Serum values of CK, glucose, BUN, electrolytes, lactate and thyroid hormones were always in the normal ranges. Blood gas controls showed a constant respiratory alkalosis, arterial pCO2 values decreasing to 20 mm Hg or less. In addition to mechanical ventilation, treatment consisted in dantrolene infusions and droperidol injections, supplemented from 1989 onward with piritramide injections because of the increased severity of myalgia. In 1991 we gave propofol by
自1983年以来,我们一直参与对一名现年48岁女性患者的诊断检查和急诊治疗,她患有类似卢夫特病的线粒体肌病。该综合征于1959年首次被描述,1962年由卢夫特等人更详细地报道,他们报告了一种高代谢的表现,伴有高温、极度出汗、心动过速、静息时呼吸困难、多饮、多食和易怒,但甲状腺功能正常。1971年和1976年,海达尔和迪·毛罗报告了第二例病例,并提出用氯霉素治疗。我们的患者是迄今为止报告的该综合征的第三例病例:她的病例最初于1987年发表。病例报告。自17岁起,该患者就反复发作发热、心动过速和出汗。32岁时,这些发作加剧,导致意识丧失和呼吸暂停。患者随后不得不插管、通气,有时还需要进行复苏。1983年首次肌肉活检后,根据生化检查结果做出了恶性高热易感性和卢夫特病的诊断。氯霉素治疗失败。1985年开始用β受体阻滞剂、维生素C、维生素K或维生素E、辅酶Q10和高热量饮食进行治疗。该患者登记了急救服务,每当她发生严重危机时,急救服务会将她送往我们的重症监护病房。对于较轻的发作,她在家中会配备氧气面罩。1988年起,随着发作次数增加,肌痛加重,患者在家中需要静脉注射丹曲林和使用镇痛药。为便于静脉穿刺,1987年植入了一个输液港系统,该系统因感染和败血症不得不四次取出。在鹿特丹进行了一次肌肉活检,结果显示线粒体功能与1983年记录的生化检查结果不同,不符合卢夫特病。不幸的是,患者无法进行进一步的代谢检查或治疗试验。麻醉。该患者在我们诊所接受了三次局部麻醉和六次全身麻醉。1983年的两次肌肉活检和1985年的一次肌肉活检是在普鲁卡因局部浸润麻醉下进行的,过程顺利。以下手术操作在预先用丹曲林预处理后,使用无恶性高热触发物质的全身麻醉:修复头臂干与右颈静脉和锁骨下静脉之间的广泛动静脉瘘、胸骨环扎修复、感染性输液港系统的植入和取出。我们使用依托咪酯、丙泊酚和芬太尼或阿芬太尼加氧化亚氮和氧气进行麻醉诱导和维持。用维库溴铵或阿曲库铵诱导肌肉松弛。所有心血管、呼吸、代谢和体温测量均保持在正常范围内。在广泛的血管修复(动静脉瘘)后,患者必须机械通气数小时,直到体温恢复正常。在所有其他麻醉期结束时,她在手术室拔管。五次术后情况平稳。只有一次她出现了高热、心动过速、出汗和呼吸困难的危机。重症监护。1985年至1992年,该患者在我们的重症监护病房接受了21次治疗。11次入院时她已被插管并由急救服务进行通气。通常在2至20小时内可以拔管。在危机期间,心率约为每分钟160 - 190次,体温高于40摄氏度。肌酸激酶、葡萄糖、尿素氮、电解质、乳酸和甲状腺激素的血清值始终在正常范围内。血气检查显示持续的呼吸性碱中毒,动脉血二氧化碳分压值降至20毫米汞柱或更低。除了机械通气外,治疗包括静脉注射丹曲林和注射氟哌利多,从1989年起,由于肌痛加重,补充注射匹利卡明。1991年我们给予丙泊酚……